Acrivon Therapeutics, Correlations
| ACRV Stock | 7.16 0.61 9.31% |
The current 90-days correlation between Acrivon Therapeutics, and Eliem Therapeutics is 0.09 (i.e., Significant diversification). The correlation of Acrivon Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Acrivon Therapeutics, Correlation With Market
Weak diversification
The correlation between Acrivon Therapeutics, Common and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.
Acrivon |
Moving together with Acrivon Stock
Moving against Acrivon Stock
| 0.35 | KZR | Kezar Life Sciences | PairCorr |
| 0.68 | HD | Home Depot | PairCorr |
| 0.61 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.57 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.54 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.52 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.51 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
| 0.49 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.45 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.43 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.4 | HPQ | HP Inc | PairCorr |
| 0.35 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| -0.01 | 0.87 | -0.52 | 0.83 | -0.66 | ELYM | ||
| -0.01 | -0.17 | 0.1 | 0.11 | 0.01 | HCWB | ||
| 0.87 | -0.17 | -0.52 | 0.72 | -0.57 | SCPH | ||
| -0.52 | 0.1 | -0.52 | -0.42 | 0.49 | MIST | ||
| 0.83 | 0.11 | 0.72 | -0.42 | -0.6 | MCRB | ||
| -0.66 | 0.01 | -0.57 | 0.49 | -0.6 | LUMO | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Acrivon Stock performing well and Acrivon Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acrivon Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELYM | 3.92 | (0.95) | 0.00 | (5.36) | 0.00 | 6.21 | 34.87 | |||
| HCWB | 13.22 | 4.45 | 0.42 | (1.48) | 7.39 | 22.00 | 352.85 | |||
| SCPH | 2.68 | (0.82) | 0.00 | (0.32) | 0.00 | 4.30 | 20.70 | |||
| MIST | 1.92 | 0.21 | 0.13 | 0.25 | 1.60 | 7.19 | 18.66 | |||
| MCRB | 4.68 | 0.01 | (0.02) | 0.25 | 5.68 | 10.00 | 28.84 | |||
| LUMO | 2.77 | 0.61 | 0.15 | (3.14) | 2.60 | 6.35 | 26.13 |
Acrivon Therapeutics, Corporate Management
| Peter MD | Chairman, CoFounder | Profile | |
| Jesper Olsen | Head CoFounder | Profile | |
| Dr MBA | Senior Affairs | Profile | |
| Katharine CPA | Vice Accounting | Profile | |
| Bruce Close | Vice Compliance | Profile | |
| MaryAlice JD | Chief Officer | Profile | |
| Crystal Mercado | Global HR | Profile |